Statements of Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Statements of Comprehensive Loss [Abstract]
Sales	$ 1,629,108	$ 1,071,970
Cost of sales (excluding depreciation expense)	544,903	380,069
Operating expenses:
Research and development	8,216,543	7,208,701
Sales and marketing	4,030,150	650,126
General and administrative	6,325,999	6,858,008
Depreciation and amortization	297,318	483,481
Total operating expenses	18,870,010	15,200,316
Loss from operations	(17,785,805)	(14,508,415)
Other (expense) income:
Interest income	582,354	431,019
Interest expense	(1,603,575)	(165,390)
Total other (expense) income	(1,021,221)	265,629
Loss before income taxes	(18,807,026)	(14,242,786)
Income tax expense	9,602	4,338
Net loss	(18,816,628)	(14,247,124)
Net loss attributable to common stockholders, basic	(18,816,628)	(14,247,124)
Net loss attributable to common stockholders, diluted	$ (18,816,628)	$ (14,247,124)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.85)	$ (0.93)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.85)	$ (0.93)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	22,267,695	15,384,376
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	22,267,695	15,384,376